Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 50090-3475

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 50090-3475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Chemical structure of Tolterodine Tartrate, the active ingredient in the product. The diagram shows the molecular composition including aromatic rings and functional groups characteristic of Tolterodine Tartrate.*
FDA Label Image

Label Image (Lbl500903475)

Label Image (Lbl500903475)
Tolterodine Tartrate 4 mg extended release capsules packaging label from A-S Medication Solutions. The label includes storage instructions to store at 68 to 77 degrees Fahrenheit, protection from light, and states the package contains 90 capsules. The route of administration is oral.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.